CDC okays use of GSK, Pfizer RSV jabs for elderly



The United States Centers for Disease Control and Prevention (CDC) recommended on Thursday that adults aged 60 and over should consider receiving an RSV vaccine made by Pfizer or GSK.

However, the re…

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento